Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Deep-Sequencing Of The Molecular Landscape In Burkitt Lymphoma/Leukemia

Alexander Kohlmann, PhD, Andreas Roller, PhD, Jennifer Kienast, Sabine Denzel, PhD, Vera Grossmann, PhD, Niroshan Nadarajah, MSc, Tamara Alpermann, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 2998.

https://doi.org/10.1182/blood.V122.21.2998.2998

Published: 2013

Journal Articles

Gene Amplifications In 84 Patients With Acute Myeloid Leukemia and 31 Patients With Myelodysplastic Syndrome Investigated By Array CGH

Andreas Roller, PhD, Simone Weber, Alexander Kohlmann, PhD, Melanie Zenger, Marita Staller, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 3724.

https://doi.org/10.1182/blood.V122.21.3724.3724

Published: 2013

Journal Articles

Targeted Next-Generation Sequencing Of 2,761 Genes Detects Copy Number States and Molecular Mutations In a Single Approach

Alexander Kohlmann, PhD, Andreas Roller, PhD, Sandra Weissmann, PhD, Sabrina Kuznia, MSc, Melanie Zenger, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 1371.

https://doi.org/10.1182/blood.V122.21.1371.1371

Published: 2013

Journal Articles

Molecular Characterization of B-Cell Neoplasms Harboring MYC Translocations

Sabine Denzel, PhD, Alexander Kohlmann, PhD, Andreas Roller, PhD, Sabine Jeromin, PhD, Tamara Alpermann, Jennifer Kienast, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 1307.

https://doi.org/10.1182/blood.V122.21.1307.1307

Published: 2013

Journal Articles

Myelodysplastic Syndromes (MDS) With 20q Deletion Show a High Frequency Of Associated Cytogenetic and Molecular Lesions With An Association To U2AF1 , SRSF2 , and Prognostically Adverse ASXL1 Mutations

Ulrike Bacher, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD, Melanie Zenger, Manja Meggendorfer, PhD, Andreas Roller, PhD, Vera Grossmann, PhD, Maria Theresa Krauth, MD, Sabine Jeromin, PhD, Tamara Alpermann, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 657.

https://doi.org/10.1182/blood.V122.21.657.657

Published: 2013

Journal Articles

TP53 Alterations In CLL - Parameters Influencing The Prognostic Impact: A Study On 3,988 Patients

Claudia Haferlach, MD, Frank Dicker, PhD, Sabine Jeromin, PhD, Sandra Weissmann, PhD, Andreas Roller, PhD, Wenke Worseg, Tamara Alpermann, Wolfgang Kern, MD, Torsten Haferlach, MD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 865.

https://doi.org/10.1182/blood.V122.21.865.865

Published: 2013

Journal Articles

A 13-Gene Panel Targeted To Investigate CLL By Next-Generation Amplicon Deep-Sequencing Can Be Successfully Implemented In Routine Diagnostics

Alexander Kohlmann, PhD, Andreas Roller, PhD, Andreia Albuquerque, PhD, Sabrina Kuznia, MSc, Sandra Weissmann, PhD, Sabine Jeromin, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2013) 122 (21): 867.

https://doi.org/10.1182/blood.V122.21.867.867

Published: 2013

Journal Articles

Analysis For Loss Of 13q Heterozygosity Using STR Or SNP Analysis Can Replace Analysis Of FLT3 -ITD To Detect Prognostically Adverse AML

Susanne Schnittger, PhD, Simone Weber, Sonja Schindela, Andreas Roller, PhD, Tamara Alpermann, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2013) 122 (21): 805.

https://doi.org/10.1182/blood.V122.21.805.805

Published: 2013

Journal Articles

Array CGH Identifies Copy Number Changes In 10% Of 520 MDS Patients With Normal Karyotype: Deletions Encompass The Genes TET2 , DNMT3A , ETV6 , NF1 , RUNX1, and STAG2 and Are Associated With Shorter Survival

Claudia Haferlach, MD, Melanie Zenger, Marita Staller, Andreas Roller, PhD, Kathrin Raitner, Jinda Holzwarth, Wolfgang Kern, MD, Susanne Schnittger, PhD, Yasunobu Nagata, MD, Seishi Ogawa, MD, PhD, Alexander Kohlmann, PhD, Torsten Haferlach, MD

Blood (2013) 122 (21): 1516.

https://doi.org/10.1182/blood.V122.21.1516.1516

Published: 2013

Journal Articles

Diagnostic and Prognostic Utility Of a 26-Gene Panel For Deep-Sequencing Mutation Analysis In Myeloid Malignancies

Alexander Kohlmann, PhD, Sabrina Kuznia, MSc, Niroshan Nadarajah, MSc, Tamara Alpermann, Sandra Weissmann, PhD, Andreas Roller, PhD, Andreia Albuquerque, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2013) 122 (21): 1547.

https://doi.org/10.1182/blood.V122.21.1547.1547

Published: 2013

Journal Articles

Tyrosine Kinase Inhibitor Treated CML Patients Harboring Philadelphia-Negative Cytogenetically Aberrant Clones Show Molecular Mutations In 31% Of Cases Not Present At Diagnosis: A High-Throughput Amplicon Sequencing Study Of 29 Genes

Susanne Schnittger, PhD, Sabrina Kuznia, MSc, Manja Meggendorfer, PhD, Niroshan Nadarajah, MSc, Sabine Jeromin, PhD, Tamara Alpermann, Andreas Roller, PhD, Andreia Albuquerque, PhD, Sandra Weissmann, PhD, Thomas Ernst, Christiane Eder, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Alexander Kohlmann, PhD, Torsten Haferlach, MD, Andreas Hochhaus, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 611.

https://doi.org/10.1182/blood.V122.21.611.611

Published: 2013

Journal Articles

Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes

Blood (2013) 122 (21): 521.

https://doi.org/10.1182/blood.V122.21.521.521

Published: 2013

Journal Articles

Prognostic Impact of NOTCH1 Mutations in Chronic Lymphocytic Leukemia (CLL): A Study On 538 Patients.

Sandra Weissmann, PhD, Andreas Roller, PhD, Vera Grossmann, MSc, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD, Alexander Kohlmann, PhD

Blood (2012) 120 (21): 2873.

https://doi.org/10.1182/blood.V120.21.2873.2873

Published: 2012

Journal Articles

Acute Erythroid Leukemia (AEL) Can Be Separated Into Distinct Prognostic Subsets Based On Cytogenetic and Molecular Genetic Characteristics

Vera Grossmann, MSc, Claudia Haferlach, MD, Susanne Schnittger, PhD, Ulrike Bacher, MD, Franziska Poetzinger, Sandra Weissmann, PhD, Andreas Roller, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Melanie Zenger, Marita Staller, Wolfgang Kern, MD, Alexander Kohlmann, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 1394.

https://doi.org/10.1182/blood.V120.21.1394.1394

Published: 2012

Journal Articles

Mixed Phenotype Acute Leukemia, T/Myeloid, NOS (MPAL-TM) Has a High DNMT3A Mutation Frequency and Carries Further Genetic Features of Both AML and T-ALL: Results of a Comprehensive Next-Generation Sequencing Study Analyzing 32 Genes

Wolfgang Kern, MD, Vera Grossmann, MSc, Andreas Roller, PhD, Sandra Weissmann, PhD, Tamara Alpermann, Ulrike Schoeck, MSc, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Alexander Kohlmann, PhD

Blood (2012) 120 (21): 403.

https://doi.org/10.1182/blood.V120.21.403.403

Published: 2012

NARROW

Deep-Sequencing Of The Molecular Landscape In Burkitt Lymphoma/Leukemia

Gene Amplifications In 84 Patients With Acute Myeloid Leukemia and 31 Patients With Myelodysplastic Syndrome Investigated By Array CGH

Targeted Next-Generation Sequencing Of 2,761 Genes Detects Copy Number States and Molecular Mutations In a Single Approach

Molecular Characterization of B-Cell Neoplasms Harboring MYC Translocations

Myelodysplastic Syndromes (MDS) With 20q Deletion Show a High Frequency Of Associated Cytogenetic and Molecular Lesions With An Association To U2AF1 , SRSF2 , and Prognostically Adverse ASXL1 Mutations

TP53 Alterations In CLL - Parameters Influencing The Prognostic Impact: A Study On 3,988 Patients

A 13-Gene Panel Targeted To Investigate CLL By Next-Generation Amplicon Deep-Sequencing Can Be Successfully Implemented In Routine Diagnostics

Analysis For Loss Of 13q Heterozygosity Using STR Or SNP Analysis Can Replace Analysis Of FLT3 -ITD To Detect Prognostically Adverse AML

Array CGH Identifies Copy Number Changes In 10% Of 520 MDS Patients With Normal Karyotype: Deletions Encompass The Genes TET2 , DNMT3A , ETV6 , NF1 , RUNX1, and STAG2 and Are Associated With Shorter Survival

Diagnostic and Prognostic Utility Of a 26-Gene Panel For Deep-Sequencing Mutation Analysis In Myeloid Malignancies

Tyrosine Kinase Inhibitor Treated CML Patients Harboring Philadelphia-Negative Cytogenetically Aberrant Clones Show Molecular Mutations In 31% Of Cases Not Present At Diagnosis: A High-Throughput Amplicon Sequencing Study Of 29 Genes

Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes

Prognostic Impact of NOTCH1 Mutations in Chronic Lymphocytic Leukemia (CLL): A Study On 538 Patients.

Acute Erythroid Leukemia (AEL) Can Be Separated Into Distinct Prognostic Subsets Based On Cytogenetic and Molecular Genetic Characteristics

Mixed Phenotype Acute Leukemia, T/Myeloid, NOS (MPAL-TM) Has a High DNMT3A Mutation Frequency and Carries Further Genetic Features of Both AML and T-ALL: Results of a Comprehensive Next-Generation Sequencing Study Analyzing 32 Genes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only